VeriMommagnolia officinalis bark extract은 임신 중 안전한가요?
No EU Annex II/III listing or harmonised CLP (H360/H361/H340/H350) was found for Magnolia officinalis bark extract; ECHA substance page lists the substance but does not show a harmonised reproductive/CMR classification. Animal/subchronic toxicity studies report effects at high oral doses but do not provide clear developmental/teratogenic evidence, and authoritative cosmetic safety bodies (CIR/SCCS) specific opinions were not found. Topical cosmetic exposure is expected to produce low but measurable systemic absorption for botanical extracts. (Sources: ECHA substance page; rat subchronic toxicity study; product/COSING listings; EWG summary).
Pregnancy-safe products containing magnolia officinalis bark extract
Related ingredients
Frequently asked questions
- magnolia officinalis bark extract은 임신 중 안전한가요?
- No EU Annex II/III listing or harmonised CLP (H360/H361/H340/H350) was found for Magnolia officinalis bark extract; ECHA substance page lists the substance but does not show a harmonised reproductive/CMR classification. Animal/subchronic toxicity studies report effects at high oral doses but do not provide clear developmental/teratogenic evidence, and authoritative cosmetic safety bodies (CIR/SCCS) specific opinions were not found. Topical cosmetic exposure is expected to produce low but measurable systemic absorption for botanical extracts. (Sources: ECHA substance page; rat subchronic toxicity study; product/COSING listings; EWG summary).
- magnolia officinalis bark extract은 모유 수유 중 안전한가요?
- No harmonised reproductive/breastfeeding hazard classification or EU cosmetic ban/restriction was identified. Human data on passage into breast milk are not available; animal studies at high oral doses show organ effects but do not document lactation-specific transfer. Topical use could result in low systemic exposure; therefore risk from topical cosmetic use is expected to be low but incompletely characterised. (Sources: ECHA; PubMed toxicity reviews; WebMD/CanABaby summaries).
- magnolia officinalis bark extract은 아기 피부에 안전한가요?
- Hazard and mechanism scores unchanged (no evidence of reproductive/developmental or endocrine-disrupting classification). Exposure score increased by +1 for infants because topical botanical extracts can be absorbed more on immature infant skin; therefore if adult topical exposure is low-measurable (1), infant exposure is moderate (2). No infant-specific dermal toxicity or developmental studies were located. (Sources: ECHA; infant-safety summaries; topical absorption rationale).
- VeriMom은 magnolia officinalis bark extract을 어떻게 평가하나요?
- VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 magnolia officinalis bark extract을 93/100 (알려진 위험 없음)로 평가합니다.
- 임신 중 magnolia officinalis bark extract 대체 안전 성분은?
- 유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.
모든 성분표를 2초 만에 확인
VeriMom 무료 다운로드 — 어떤 제품이든 스캔해 임신 중 안전 점수를 즉시 확인하세요.
의료 면책 조항
이 정보는 교육 목적으로만 제공되며 의학적 조언을 구성하지 않습니다. 안전 점수는 공개적으로 이용 가능한 데이터를 기반으로 하며 모든 위험을 반영하지 않을 수 있습니다. 임신 중 또는 수유 중 제품을 사용하기 전에 항상 의료 전문가와 상담하십시오.